CDT EQUITY INC. Shares Issued
CDT EQUITY INC. (CDT) had Shares Issued of 631.08 thousand shares as of 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-09-08
- 2026-06-30: Common Stock, Shares, Issued 631.08K shares.
- 2026-03-31: Common Stock, Shares, Issued 4.72M shares.
- 2025-12-31: Common Stock, Shares, Issued 9.21K shares; Common Stock, Shares, Issued as first filed 92.14K shares.
- 2025-09-30: Common Stock, Shares, Issued 1.28M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 631.08K shares S-1 · filed 2026-09-08 | |
| 2026-03-31 | 4.72M shares 10-Q · filed 2026-07-15 | |
| 2025-12-31 | 9.21K shares S-1 · filed 2026-09-08 | 92.14K shares 10-K · filed 2026-04-15 |
| 2025-09-30 | 1.28M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 2.41M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 9.51M shares 10-Q/A · filed 2025-08-14 | |
| 2024-12-31 | 46.00 shares S-1 · filed 2026-09-08 | 1.38M shares 10-K · filed 2025-03-28 |
| 2024-09-30 | 96.00M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 74.00M shares 10-Q/A · filed 2024-11-14 | |
| 2023-12-31 | 738.29K shares 10-K · filed 2025-03-28 | 73.83M shares 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |